TY - JOUR
T1 - Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients
T2 - A Systematic Review with Qualitative Evidence Synthesis
AU - Giacobbe, Daniele R
AU - Cortegiani, Andrea
AU - Karaiskos, Ilias
AU - Mercier, Toine
AU - Tejada, Sofia
AU - Peghin, Maddalena
AU - Grecchi, Cecilia
AU - Rebuffi, Chiara
AU - Asperges, Erika
AU - Zuccaro, Valentina
AU - Scudeller, Luigia
AU - Bassetti, Matteo
AU - de Lange, Prof.dr. D.W. (Dylan)
N1 - Funding Information:
Funding: The present project did not require additional funding from routine research activities. Costs for open-access publications were covered by research funds of the main authors.
Funding Information:
Conflicts of Interest: Outside the submitted work, M.B. has received funding for scientific advisory boards, travel, and speaker honoraria from Angelini, Astellas, AstraZeneca, Basilea, Bayer, BioMérieux, Cidara, Correvio, Cubist, Menarini, Molteni, MSD, Nabriva, Paratek, Pfizer, Roche, Shionogi, Tetraphase, Thermo Fisher, and The Medicine Company. D.R.G. reports personal fees from Stepstone Pharma GmbH and unconditional grants from MSD Italia and Correvio Italia. The other authors report no conflicts of interest.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/2/28
Y1 - 2021/2/28
N2 - The Fungal Infections Definitions in Intensive Care Unit (ICU) patients (FUNDICU) project aims to provide standard sets of definitions for invasive fungal diseases (IFDs) in critically ill, adult patients, including invasive aspergillosis (IA), invasive candidiasis (IC), Pneumocystis jirovecii pneumonia (PJP), and other non-IA, non-IC IFDs. The first step of the project was the conduction of separated systematic reviews of the characteristics and applicability to critically ill, adult patients outside classical populations at risk (hematology patients, solid organ transplant recipients) of available definitions and diagnostic tests for IFDs. We report here the results of two systematic reviews exploring the performance of available definitions and tests, for PJP and for other non-IA, non-IC IFDs. Starting from 2585 and 4584 records for PJP and other IFDs, respectively, 89 and 61 studies were deemed as eligible for full-text evaluation. However, only two studies for PJP and no studies for other IFDs met the FUNDICU protocol criteria for inclusion in qualitative synthesis. Currently, there is no sufficient solid data for directly evaluating the performance of existing definitions and laboratory tests for the diagnosis of PJP and other non-IA, non-IC IFDs in critically ill adult patients outside classical populations at risk.
AB - The Fungal Infections Definitions in Intensive Care Unit (ICU) patients (FUNDICU) project aims to provide standard sets of definitions for invasive fungal diseases (IFDs) in critically ill, adult patients, including invasive aspergillosis (IA), invasive candidiasis (IC), Pneumocystis jirovecii pneumonia (PJP), and other non-IA, non-IC IFDs. The first step of the project was the conduction of separated systematic reviews of the characteristics and applicability to critically ill, adult patients outside classical populations at risk (hematology patients, solid organ transplant recipients) of available definitions and diagnostic tests for IFDs. We report here the results of two systematic reviews exploring the performance of available definitions and tests, for PJP and for other non-IA, non-IC IFDs. Starting from 2585 and 4584 records for PJP and other IFDs, respectively, 89 and 61 studies were deemed as eligible for full-text evaluation. However, only two studies for PJP and no studies for other IFDs met the FUNDICU protocol criteria for inclusion in qualitative synthesis. Currently, there is no sufficient solid data for directly evaluating the performance of existing definitions and laboratory tests for the diagnosis of PJP and other non-IA, non-IC IFDs in critically ill adult patients outside classical populations at risk.
KW - Biomarker
KW - Diagnosis
KW - IFD
KW - Invasive fungal diseases
KW - PJP
KW - Pneumocystis
UR - http://www.scopus.com/inward/record.url?scp=85102297603&partnerID=8YFLogxK
U2 - 10.3390/jof7030176
DO - 10.3390/jof7030176
M3 - Review article
C2 - 33670864
SN - 2309-608X
VL - 7
SP - 1
EP - 9
JO - Journal of fungi (Basel, Switzerland)
JF - Journal of fungi (Basel, Switzerland)
IS - 3
M1 - 176
ER -